Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
-loop drug discovery. The project aims to establish an integrated Design–Make–Test–Analyze (DMTA) platform combining generative AI, ultra-large synthetically accessible chemical spaces, physics-informed
-
than 18,500 people, including over 14,000 students and 4,000 researchers from more than 120 different countries. Postdoc in ML-Based Co-Design at EPFL Mission The EPFL computer vision lab (https://www.epfl.ch
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
experience to establish themselves as future group leaders at Empa. This is part of our broader commitment outlined in our Diversity Action Plan and relates to specific goals that are regularly implemented
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
6,500 people supporting the three main missions of the institutions: education, research and innovation. The EPFL campus offers an exceptional working environment at the heart of a community of more
-
Newsweek. The Department of Oral and Craniomaxillofacial Surgery combines high-level clinical care with advanced digital innovation, translational research and patient-specific technologies. The in-house